KI-Beratung Beta

Produktbild: Antiarrhythmic Drugs

Antiarrhythmic Drugs Mechanisms of Antiarrhythmic and Proarrhythmic Actions

Fr. 137.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.08.2012

Abbildungen

XII, 410 p. 300 illus.

Herausgeber

Günter Breithardt + weitere

Verlag

Springer Berlin

Seitenzahl

410

Maße (L/B/H)

23.5/15.5/2.3 cm

Gewicht

639 g

Auflage

Softcover reprint of the original 1st edition 1995

Sprache

Englisch

ISBN

978-3-642-85626-6

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.08.2012

Abbildungen

XII, 410 p. 300 illus.

Herausgeber

Verlag

Springer Berlin

Seitenzahl

410

Maße (L/B/H)

23.5/15.5/2.3 cm

Gewicht

639 g

Auflage

Softcover reprint of the original 1st edition 1995

Sprache

Englisch

ISBN

978-3-642-85626-6

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Antiarrhythmic Drugs
  • Basic Mechanisms of Antiarrhythmic Drug Action.- Sodium Channel Blockade as an Antiarrhythmic Mechanism.- Pharmacology of T and L type Ca2+ Channels in Cardiac Tissue.- Molecular Biology and Ion Channel Biophysics: Their Role in Rational Pharmacological Antiarrhythmic Therapy.- Selective Pharmacological Modification of Repolarizing Currents: Antiarrhythmic and Proarrhythmic Actions of Agents that Influence Repolarization of the Heart.- A Shift from Class to Class III Drugs in the Medical Treatment of Arrhythmias: Wishful Thinking?.- Use Dependence and Reverse Use Dependence of Antiarrhythmic Agents: Pro-and Antiarrhythmic Actions.- Modulation of Antiarrhythmic Drug Action by Disease and Injury.- Interaction of Transient Ischemia with Antiarrhythmic Drugs.- Management of Patients with Sustained Ventricular Tachyarrhythmias: Differnt Clinical Studies, Different Patients.- Antiarrhythmic Drug Action: Modulation by Disease and Injury.- Reentrant Excitation: Pharmacological Interactions.- Pharmacological Modulation of Reentrant Excitation in Experimental Models.- Reentry in Clinical Arrhythmias: Mechanisms Responsible for Antiarrhythmic Drug Efficacy.- Variability of the Arrhythmogenic Substrate: Drug Influences.- Experimental Models for the Assessment of Antiarrhythmic and Proarrhythmic Drug Action: Traditional and Newer Models.- Influence of the Autonomic Nervous System on the Action of Antiarrhythmic Drugs.- Role of Drugs in Torsade de Pointes and Triggered Activity.- The Study of Pharmacokinetics and Pharmacodynamics as a Tool for Understanding Mechanisms of Antiarrhythmic Drug Action.- Electrophysiologic Effects, Clinical Efficacy and Antiarrhythmic and Proarrhythmic Effects of Sodium Channel Blockers in Patients with Ventricular Tachyarrhythmias.- Antiarrhythmic VersusProarrhythmic Effects of Class III Agents.- “Novel” Antiarrhythmic Drugs.- Electrophysiologic Properties and Antiarrhythmic Effects of Adenosine and Adenosine Triphosphate.- Magnesium-Electrophysiological Effects, Antiarrhythmic Properties and Clinical Applications.- Future Perspectives.- The Classification of Antiarrhythmic Drugs: How do we Educate the Scientist and the Clinician?.